⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
globenewswire.com
SRPT
ALNY
DNLI
ARCT
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
prnewswire.com
GSK
BIIB
LLY
MRK
TAK
ALNY
BMY
NVS
REGN
VRTX
Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain
globenewswire.com
ALNY
SAIL
EXEL
Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain
globenewswire.com
ALNY
SAIL
EXEL
RNA Therapies Market Research and Competitive Landscape Report 2026
globenewswire.com
NVS
ARWR
ALNY
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
globenewswire.com
NVS
ALNY
IONS
Next Generation Drug Conjugates (NDCs) Market worth $42.55 billion by 2035 | MarketsandMarkets™
prnewswire.com
ALNY
GILD
IONQ
ABBV
ARWR
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
businesswire.com
ALNY
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis
businesswire.com
ALNY
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
businesswire.com
ALNY